(1)
Dumusc, A.; Ng, W.-F.; James, K.; Griffiths, B.; Price, E.; Pease, C. T.; Emery, P.; Lanyon, P.; Jones, A.; Bombardieri, M.; Sutcliffe, N.; Pitzalis, C.; Gupta, M.; McLaren, J.; Cooper, A.; Giles, I.; Isenberg, D.; Saravanan, V.; Coady, D.; Dasgupta, B.; McHugh, N.; Young-Min, S.; Moots, R. J.; Gendi, N.; Akil, M.; Barone, F.; Fisher, B. A.; Rauz, S.; Richards, A.; Bowman, S. J.; on behalf of the UK primary Sjögren’s Syndrome Registry. Comparison of ESSDAI and ClinESSDAI in Potential Optimisation of Trial Outcomes in Primary Sjögren’s Syndrome: Examination of Data from the UK Primary Sjögren’s Syndrome Registry. Swiss Med Wkly 2018, 148, w14588.